← FDA Drug Approvals (Drugs@FDA)

VYVANSE

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2017-01-28

Drug application

FDA Application #

NDA208510

Application type

New Drug Application

Brand name

VYVANSE

Generic name

LISDEXAMFETAMINE DIMESYLATE

Active ingredients

LISDEXAMFETAMINE DIMESYLATE

Dosage form

TABLET, CHEWABLE

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2017-01-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown